Effect of Glycodiazine on Blood Sugar in Diabetes Mellitus

Clinical trials were made with glycodiazine, N.(5(2-Methoxyethoxy)-2-Pyrimidinyl) benzenesulfonamide by a technic in which the effects of the drug were compared statistically to those of a placebo in a group of patients with the adult onset type of diabetes mellitus. Glycodiazine was active orally at two dosage levels 0.5 gm. b.i.d. and 0.5 grn. once a day although onset of antihyperglycemic response was slower with the smaller dose. No untoward side effects were noticed. The findings indicate that glycodiazine may be an effective oral antihyperglycemic agent.